316
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Rehmannioside A Inhibits TRAF6/MAPK Pathway and Improves Psoriasis by Interfering with the Interaction of HaCaT Cells with IL-17A

&
Pages 2585-2596 | Received 14 Jul 2023, Accepted 12 Sep 2023, Published online: 21 Sep 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Congrong Wang, Naixiang Zhou, Mingcui Li & Haixia Chen. (2024) Rehmannioside A inhibits the activity of CYP3A4, 2C9 and 2D6 in vitro. Xenobiotica 0:0, pages 1-6.
Read now

Articles from other publishers (3)

Stephen A. Bustin. (2024) Improving the quality of quantitative polymerase chain reaction experiments: 15 years of MIQE. Molecular Aspects of Medicine 96, pages 101249.
Crossref
Zheng Wei, Hongfa Zhong, Shanmin Yuan & Cong Chen. (2024) Daturataturin A Ameliorates Psoriasis by Regulating PPAR Pathway. Biochemical Genetics.
Crossref
Yuankang Feng, Zhenlin Huang, Liang Song, Ningyang Li, Xiang Li, Huihui Shi, Ruoyang Liu, Fubo Lu, Xu Han, Yafei Ding, Yinghui Ding, Jun Wang, Jinjian Yang & Zhankui Jia. (2024) PDE3B regulates KRT6B and increases the sensitivity of bladder cancer cells to copper ionophores. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref